Driven by rapidly advancing scientific innovation, China has entered into an unprecedented era of pharmaceutical drug development. The biotech industry continues to evolve, with oncology remaining at the forefront.
Zentera Therapeutics (Shanghai), established in 2020, is a clinical-stage biotechnology company committed to improving the lives of cancer patients. Our mission is to develop transformative therapies targeting apoptosis, synthetic lethality and other tumor biological mechanisms for difficult-to-treat tumors. We look forward to what the future holds for our promising product candidates.
Our team is comprised of seasoned leaders with extensive experience spanning drug discovery, clinical development, regulatory and commercial. We are motivated by our ambitions to become entrepreneurs.
Zentera was created at an opportune time in response to positive trends within the Chinese healthcare market and we are excited to work with other global leaders to end cancer.